NUWELLIS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
NUWELLIS, INC. (NUWE) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$10.12 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-21.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-02-21
- NUWELLIS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$2.74M, a 120.96% decline year-over-year.
- NUWELLIS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $1.23M.
- NUWELLIS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$3.51M, a 190.04% decline year-over-year.
- NUWELLIS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$5.09M, a 1606.21% decline year-over-year.
- NUWELLIS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$10.12M, a 170.87% decline from fiscal 2017.
- NUWELLIS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $14.27M.
- NUWELLIS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$21.79M.
- NUWELLIS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$8.18M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | -$1.51M derived: sum of 2 quarters · filed 2019-02-21 | -$5.02M derived: sum of 3 quarters · filed 2019-02-21 | -$10.12M 10-K · filed 2019-02-21 |
| 2018-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$2.28M derived: sum of 2 quarters · filed 2018-11-07 | -$7.37M 10-Q · filed 2018-11-07 | $5.71M derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-06-30 | -$3.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$8.60M 10-Q · filed 2018-08-09 | $4.48M derived: sum of 3 quarters · filed 2019-02-21 | $1.44M derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-03-31 | -$5.09M 10-Q · filed 2018-05-10 | $7.99M derived: sum of 2 quarters · filed 2019-02-21 | $4.95M derived: sum of 3 quarters · filed 2019-02-21 | $8.84M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-12-31 | $13.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $10.04M derived: sum of 2 quarters · filed 2019-02-21 | $13.93M derived: sum of 3 quarters · filed 2019-02-21 | $14.27M 10-K · filed 2019-02-21 |
| 2017-09-30 | -$3.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $852.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.19M 10-Q · filed 2018-11-07 | $1.72M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $4.24M 10-Q · filed 2018-08-09 | $4.77M derived: sum of 3 quarters · filed 2018-08-09 | -$6.49M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $338.00K 10-Q · filed 2018-05-10 | $869.00K derived: sum of 2 quarters · filed 2018-05-10 | -$10.39M derived: sum of 3 quarters · filed 2018-05-10 | -$14.81M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $531.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | -$10.73M derived: sum of 2 quarters · filed 2018-03-22 | -$15.15M derived: sum of 3 quarters · filed 2018-03-22 | -$21.79M 10-K · filed 2018-03-22 |
| 2016-09-30 | -$11.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$15.68M derived: sum of 2 quarters · filed 2017-11-02 | -$22.32M 10-Q · filed 2017-11-02 | -$27.11M derived: sum of 4 quarters · filed 2017-11-02 |
| 2016-06-30 | -$4.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$11.06M 10-Q · filed 2017-08-10 | -$15.85M derived: sum of 3 quarters · filed 2017-08-10 | -$21.37M derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | -$6.64M 10-Q · filed 2017-05-12 | -$11.43M derived: sum of 2 quarters · filed 2017-05-12 | -$16.95M derived: sum of 3 quarters · filed 2017-05-12 | -$20.56M derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | -$4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | -$10.31M derived: sum of 2 quarters · filed 2017-03-08 | -$13.91M derived: sum of 3 quarters · filed 2017-03-08 | -$8.18M 10-K · filed 2017-03-08 |
| 2015-09-30 | -$5.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$9.13M derived: sum of 2 quarters · filed 2016-11-14 | -$3.39M 10-Q · filed 2016-11-14 | -$8.68M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | -$3.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $2.13M 10-Q · filed 2016-08-11 | -$3.16M derived: sum of 3 quarters · filed 2016-08-11 | -$8.71M derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | $5.73M 10-Q · filed 2016-05-05 | $452.00K derived: sum of 2 quarters · filed 2016-05-05 | -$5.10M derived: sum of 3 quarters · filed 2016-05-05 | |
| 2014-12-31 | -$5.28M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$10.83M derived: sum of 2 quarters · filed 2016-03-15 | -$22.84M 10-K · filed 2016-03-15 | |
| 2014-09-30 | -$5.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$17.56M 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | -$12.01M 10-Q · filed 2015-08-05 | |||
| 2013-12-31 | $39.91M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |